-
Cliché but True: Keep Calm and Carry On
Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of the day. Read more below. Happy Lunar New Year to all our readers! The U.S. FDA has given full approval to Moderna’s COVID-19 vaccine, henceforth known as Spikevax (VOA News,…
-
TAG Holds Guarded Optimism for the Ebbing of Omicron
Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine Rule. On Tuesday, OSHA announced its withdrawal of the November 5, 2021, ETS issued to “protect unvaccinated employees of large employers (100 or more employees) from the risk of contracting…
-
What Does an Endemic COVID Really Mean?
Key Points: In today’s Recommendations for Industry, we discuss the ebbing of Omicron and what a shift to an endemic COVID would really mean. Read more below. The FDA is limiting the use of the following two monoclonal antibodies – (a) bamlanivimad and etesevimab and (b) REGEN-COV – to treat COVID-19 as they are “highly…
-
COVID Case Rates Following Predictable Pattern
Key Points: In today’s Recommendations for Industry, we discuss Omicron’s path across the US. Read more below. U.S. hospitals have been inundated with Omicron cases; yet, as the vaccine mandate for healthcare workers becomes effective March 15, there is increasing fear that hospital systems may lose some workers. Additionally, despite signs that Omicron causes milder…
-
Build Your Systems for COVID’s Next Wave
Key Points: In today’s Recommendations for Industry, we discuss the business management of COVID’s next wave … whatever that may be. Read more below. As you’ve most likely heard, the Supreme Court has halted the COVID-19 vaccine rule for U.S. businesses. (AP News). Canada approves of Pfizer’s COVID-19 pill to be used “for adult patients…
-
Even Unrelated Vaccines Can Help Protect Against COVID-19
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID. Read more below. A recently published study found that SARS-CoV-2 infection during pregnancy is associated with an increased risk for adverse pregnancy outcomes, including induced abortion, cesarean sections, preterm birth…
-
Omicron in the US: Likely in the Calm before a Surge
Key Points In today’s Recommendations for Industry, we discuss the rise of Omicron. Read more here. COVID deaths in the US surpass 800,000 (NYT). It is the highest known number of any country. Known virus cases in the US rose above 50 million and more than 1,200 people are dying from COVID-19 each day. The worldwide…
-
Omicron: A Beginning Understanding?
Key Points In today’s Recommendations for Industry, we discuss Omicron and what is beginning to be understood. Read more below. The CDC is currently recommending Americans avoid travel to France, Jordan, and Portugal as these countries have seen spikes in COVID-19 cases (The Hill). Additionally, the CDC has added other destinations to Level 4 travel…
-
‘Tis the Season…
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased discussions regarding the Omicron variant (including its many mutations and potential to affect transmissibility and potential for evading human antibodies), TAG released a Newsletter Special Edition. Please find that here.…
-
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic The omicron variant of COVID-19, which was first identified in South Africa, has been detected in multiple countries, including many in Europe as well as Israel, Hong Kong, and Canada – and we can reasonably assume that it is in the U.S.…